Institute of Immunology and Immunotherapy Immunology is at the forefront of medical research and we are among the leaders of this exciting, fast-evolving field.
News £17.9m for Advanced Therapy Treatment Centre network to bolster UK clinical trial infrastructure The network includes the Midlands-Wales Advanced Therapy Treatment Centre, jointly delivered by University of Birmingham and University Hospitals Birmingham.
News BactiVac Network awarded £700k by the UK Vaccine Network Project to focus on potential epidemics
17 April 2024 Launch of new international medical code for presymptomatic type 1 diabetes University of Birmingham and NHS England researchers have created a diagnostic code for presymptomatic type 1 diabetes to enhance healthcare treatment.
21 March 2024 Birmingham Professor Gary Middleton appointed as ECMC Network Lead Professor Gary Middleton, Professor of Oncology, will be at the forefront of pioneering cancer research as ECMC Network Lead.
19 March 2024 Removal of incorrect penicillin allergy labels by non-specialist healthcare professional feasible 97% of patients who were deemed low risk and took part were assessed as not having allergy
12 March 2024 Future vaccine makers to get VR-assisted training centre of excellence University of Birmingham will lead UK-wide training to address critical skills demand in life sciences
04 March 2024 New research will target earliest stages of bone marrow cancer The opportunity to eradicate a major and incurable bone marrow cancer has been made possible with a new programme funded by Cancer Research UK.
02 February 2024 New research into autoimmune liver condition suggests unique cell movements may be driving disease A Birmingham study reveals a novel cellular phenomenon could be responsible for the onset of primary biliary cholangitis (PBC).
02 February 2024 Immune cells lose ‘killer instinct’ in cancerous tumours – but functionality can be re-awakened First study tracking how NK cells respond in tumours found that stimulating the IL-15 pathway prevented the rapid loss of function and improved tumour control